11/8/2022 8:14:40 AM
Black Diamond Therapeutics Q3 Net Loss $21.7 Mln Vs Loss $35.1 Mln Last Year
6/1/2022 7:17:28 AM
Black Diamond Therapeutics Appoints Sergey Yurasov As Chief Medical Officer
4/7/2022 7:11:49 AM
Black Diamond Therapeutics Appoints Wendy Dixon To Board
3/29/2022 8:02:20 AM
Wedbush Cuts Black Diamond Therapeutics (BDTX) To Neutral From Outperform With $4 Down From $22 Price Target
1/11/2022 7:09:41 AM
Black Diamond Therapeutics Announces FDA Allowance Of IND Application For BDTX-153 For Gliobastoma And NSCLC